New Jersey lawmakers have taken a major step toward legalizing regulated psilocybin therapy for adults with qualifying health conditions, with plans to continue working toward final enactment in the 2026 legislative session. The Assembly Health Committee recently reported the bill out favorably after hearing testimony from advocates and stakeholders, though the amended version removes broader legalization provisions for adult use.
Under the bill, the Department of Health would oversee licensing for psilocybin manufacturers, service centers, testing labs, facilitators, and workers. Access would require a referral from a licensed healthcare professional and include mandatory preparation and integration sessions. A social equity program would help low-income individuals afford treatment, and a Psilocybin Advisory Board would set guidelines and oversee safety protocols.
Support for therapeutic psilocybin remains strong among New Jersey residents, with a recent poll showing 55% in favor of doctor-supervised access. The bill now moves to the Appropriations Committee, with the Senate version having already cleared two panels.
For more details, read the full article at Marijuana Moment.